<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG, Biologics Innovation Group. To nurture an Eco-system for Biologics innovation and imprint China on Global map.</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 30 Mar 2021 21:28:56 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>连续失利“T+D”方案，肝癌疗效可期，能助AZ一局？</title><link>https://mp.weixin.qq.com/s/r4mS_nTt5rRk9W7a-XBgEQ</link><description></description><content:encoded><![CDATA[连续失利“T+D”方案，肝癌疗效可期，能助AZ一局？]]></content:encoded><pubDate>Tue, 30 Mar 2021 19:18:58 +0800</pubDate></item><item><title>新江湖｜张高华奥生命科学加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/Gvm6HM3a6Ka-zFsRuX9Xnw</link><description></description><content:encoded><![CDATA[新江湖｜张高华奥生命科学加入BiG会员机构！]]></content:encoded><pubDate>Tue, 30 Mar 2021 19:18:58 +0800</pubDate></item><item><title>ADCC效应强于IgG，IgA成药难点和工程改造!</title><link>https://mp.weixin.qq.com/s/zQ17dUwXo8hJFfN35g00Cw</link><description></description><content:encoded><![CDATA[ADCC效应强于IgG，IgA成药难点和工程改造!]]></content:encoded><pubDate>Mon, 29 Mar 2021 17:49:42 +0800</pubDate></item><item><title>荐 | 首届中国生物计算大会报名火热开启！</title><link>https://mp.weixin.qq.com/s/sq5hSEPmXeDLLZTN-leCzA</link><description></description><content:encoded><![CDATA[荐 | 首届中国生物计算大会报名火热开启！]]></content:encoded><pubDate>Mon, 29 Mar 2021 17:49:42 +0800</pubDate></item><item><title>被忽视的自身免疫疾病！</title><link>https://mp.weixin.qq.com/s/wDlzhOcIBeKKTJLU827x_Q</link><description></description><content:encoded><![CDATA[被忽视的自身免疫疾病！]]></content:encoded><pubDate>Sun, 28 Mar 2021 10:13:10 +0800</pubDate></item><item><title>荐 | 70+单抗&amp;双抗&amp;ADC生物药企领袖及研发负责人4月聚首申城</title><link>https://mp.weixin.qq.com/s/ALz0TP7CZKeDFe-3JuF76w</link><description></description><content:encoded><![CDATA[荐 | 70+单抗&双抗&ADC生物药企领袖及研发负责人4月聚首申城]]></content:encoded><pubDate>Sun, 28 Mar 2021 10:13:10 +0800</pubDate></item><item><title>肿瘤治疗新秀：mRNA疫苗</title><link>https://mp.weixin.qq.com/s/_rCeywzhsNwr6yRR4JuPoQ</link><description></description><content:encoded><![CDATA[肿瘤治疗新秀：mRNA疫苗]]></content:encoded><pubDate>Fri, 26 Mar 2021 17:07:20 +0800</pubDate></item><item><title>LAG-3会不会是IO新爆款？</title><link>https://mp.weixin.qq.com/s/CaCx2DhhxrB6FG_65HJzuA</link><description></description><content:encoded><![CDATA[LAG-3会不会是IO新爆款？]]></content:encoded><pubDate>Fri, 26 Mar 2021 17:07:20 +0800</pubDate></item><item><title>14天读书会，6位作者亲自领读，快速入门药品专利链接与延长制度！</title><link>https://mp.weixin.qq.com/s/A6L5MkX-fNIlpMynCAR4OA</link><description></description><content:encoded><![CDATA[14天读书会，6位作者亲自领读，快速入门药品专利链接与延长制度！]]></content:encoded><pubDate>Fri, 26 Mar 2021 17:07:20 +0800</pubDate></item><item><title>BiG年会 | 9位主席集结，寻找下一个创药蓝海！</title><link>https://mp.weixin.qq.com/s/iBKzYyk4srWZ0EwXpqnvLg</link><description></description><content:encoded><![CDATA[BiG年会 | 9位主席集结，寻找下一个创药蓝海！]]></content:encoded><pubDate>Wed, 24 Mar 2021 17:24:01 +0800</pubDate></item><item><title>盘点！ADC药物江湖</title><link>https://mp.weixin.qq.com/s/SIIoHsvcQooH2sF4xZ_rjQ</link><description></description><content:encoded><![CDATA[盘点！ADC药物江湖]]></content:encoded><pubDate>Wed, 24 Mar 2021 17:24:01 +0800</pubDate></item><item><title>BiG春季聚会 | ADC热潮下的临床冷思考！</title><link>https://mp.weixin.qq.com/s/e003fKfdLfh5N5LDHLZ70Q</link><description></description><content:encoded><![CDATA[BiG春季聚会 | ADC热潮下的临床冷思考！]]></content:encoded><pubDate>Mon, 22 Mar 2021 17:48:41 +0800</pubDate></item><item><title>15款产品蜂拥入临床，PROTAC能否重塑小分子荣光？</title><link>https://mp.weixin.qq.com/s/cxnPmM4x2AZ3L5FA7tbKcw</link><description></description><content:encoded><![CDATA[15款产品蜂拥入临床，PROTAC能否重塑小分子荣光？]]></content:encoded><pubDate>Sun, 21 Mar 2021 09:38:37 +0800</pubDate></item><item><title>杨森新型TCB双抗：选择性招募γδT细胞亚群</title><link>https://mp.weixin.qq.com/s/Qw4d9O23oV_CHGP6zH8D_A</link><description></description><content:encoded><![CDATA[杨森新型TCB双抗：选择性招募γδT细胞亚群]]></content:encoded><pubDate>Fri, 19 Mar 2021 16:30:59 +0800</pubDate></item><item><title>明星双抗，临床败北的启示！</title><link>https://mp.weixin.qq.com/s/0uLfi2BljwwiYKm01iqHhA</link><description></description><content:encoded><![CDATA[明星双抗，临床败北的启示！]]></content:encoded><pubDate>Fri, 19 Mar 2021 16:30:59 +0800</pubDate></item><item><title>科望智造！苏州工艺开发和中试生产基地正式落成！</title><link>https://mp.weixin.qq.com/s/HZJOcWCpvNCJz-_5v4_13Q</link><description></description><content:encoded><![CDATA[科望智造！苏州工艺开发和中试生产基地正式落成！]]></content:encoded><pubDate>Thu, 18 Mar 2021 15:51:09 +0800</pubDate></item><item><title>新江湖｜百英生物加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/4yyBZYk49yE5f1g7Fm7vkg</link><description></description><content:encoded><![CDATA[新江湖｜百英生物加入BiG会员机构！]]></content:encoded><pubDate>Thu, 18 Mar 2021 15:51:09 +0800</pubDate></item><item><title>T细胞导向疗法中双抗的空间因素</title><link>https://mp.weixin.qq.com/s/_sxKtTN3UixavRqG9Hr_gg</link><description></description><content:encoded><![CDATA[T细胞导向疗法中双抗的空间因素]]></content:encoded><pubDate>Tue, 16 Mar 2021 22:07:18 +0800</pubDate></item><item><title>新江湖｜邦耀生物加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/YZvtq0XG4nDhGE5DiMwL7g</link><description></description><content:encoded><![CDATA[新江湖｜邦耀生物加入BiG会员机构！]]></content:encoded><pubDate>Tue, 16 Mar 2021 22:07:18 +0800</pubDate></item></channel></rss>